Watchlist Price Alert

Ligand Pharmaceuticals (LGND)

NASDAQ: LGND · Real-Time Price · USD

113.41

-1.60 (-1.39%)

At close: Jun 17, 2025, 10:36 AM

Ligand Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-4.03M	52.15M	-33.36M	57.14M	-2.98M	629.3M	143.32M	12.56M	-2.37M
Depreciation & Amortization	33.91M	35.64M	51.37M	50.95M	27.97M	43.73M	14.72M	11.71M	11.29M
Stock-Based Compensation	41.09M	25.74M	60.28M	38.78M	30.73M	24.52M	20.85M	24.91M	18.89M
Other Working Capital	n/a	-16.23M	1.64M	-21.95M	35.04M	-9.57M	-2.21M	-524K	518K
Other Non-Cash Items	21.2M	-41.26M	-26.84M	-7.29M	28M	-797.5M	24.29M	11.3M	35.11M
Deferred Income Tax	n/a	11.7M	20.72M	-8.62M	-19.05M	74.83M	29.74M	44.52M	10.7M
Change in Working Capital	n/a	-34.4M	65.68M	-52.16M	-10.06M	-4.21M	-38.85M	-11.44M	-10.62M
Operating Cash Flow	97.05M	49.58M	137.85M	78.8M	54.59M	-29.34M	194.06M	93.57M	63M
Capital Expenditures	-1.82M	-3.52M	-17.92M	-8.76M	-4.46M	-2.55M	-11.89M	-7.15M	-28.32M
Cash Acquisitions	-92M	-10.4M	-750K	494K	-383.32M	-12.84M	-5.86M	-26.65M	-94.2M
Purchase of Investments	-200.6M	-142.01M	-51.23M	-181.32M	-422.52M	-2.36B	-1.43B	-254.26M	-164.44M
Sales Maturities Of Investments	262.5M	194.17M	234.39M	221.34M	1.04B	2.03B	1.02B	196.63M	143.47M
Other Investing Acitivies	-111.75M	-49.91M	-868K	-1.22M	3.26M	808.13M	3.91M	7.25M	300K
Investing Cash Flow	-143.66M	-11.68M	163.62M	30.52M	231.65M	466.92M	-423.27M	-84.18M	-143.19M
Debt Repayment	-25K	-76.9M	-261M	-146.01M	-231.76M	-27.32M	532.33M	n/a	n/a
Common Stock Repurchased	n/a	-4.55M	-8.24M	-18.45M	-78M	-453.05M	-122.87M	-1.97M	-3.9M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	60.03M	16.95M	-6.75M	8.25M	-789K	-383K	-77.11M	-5.56M	-999K
Financial Cash Flow	97.57M	-59.95M	-275.99M	-137.76M	-310.55M	-485.17M	328.58M	-7.52M	1.51M
Net Cash Flow	49.35M	-22.05M	25.48M	-28.44M	-24.31M	-47.51M	99.16M	1.87M	-78.68M
Free Cash Flow	95.23M	-4.27M	119.93M	70.04M	50.13M	-31.89M	182.17M	86.41M	34.68M